PDA-based documentation of medication interventions in an ambulatory care setting

Journal of Pharmacy Technology

Volumn 23, Issue 1, 2007, Pages 9-15

  Fit, Kathy E ^a   Burkiewicz, Jill S ^a   Sweeney, Brooke L ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CARDIAC AGENT; DIURETIC AGENT; HERBACEOUS AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CLINICAL PHARMACY; DRUG INFORMATION; DRUG MONITORING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; PATIENT EDUCATION; PERSONAL DIGITAL ASSISTANT; PHARMACEUTICAL CARE; PHARMACIST; PHYSICIAN ATTITUDE; PREDICTION; TEACHING HOSPITAL; UNSPECIFIED SIDE EFFECT; URBAN AREA;

EID: 33847092592     PISSN: 87551225     EISSN: None     Source Type: Journal    
DOI: 10.1177/875512250702300103     Document Type: Article

References (38)

1. Wilson T, Sheikh A. Enhancing public safety in primary care. BMJ 2002;324:584-7.
2. Kohn LT, Corrigan JM, Donaldson MS, eds. To err is human. Building a safer health system. Washington, DC: National Academy Press, 1999.
3. US Food and Drug Administration Center for Drug Evaluation and Research. Medication errors, www.fda.gov/cder/handbook/mederror.htm (accessed 2004 Aug 14).
4. National Coordinating Council for Medication Error Reporting and Prevention. What is a medication error? www.nccmerp.org/aboutMedErrors.html (accessed 2006 Mar 31).
5. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the clinician's guide. 2nd ed. New York: McGraw-Hill, 2004.
6. Morris CJ, Cantrill JA, Hepler CD, Noyce PR. Preventing drug-related morbidity-determining valid indicators. Int J Qual Health Care 2002;14:183-98.
7. Sandars J, Esmail A. The frequency and nature of medical error in primary care: understanding the diversity across studies. Fam Pract 2003;20:231-6.
8. Cunningham G, Dodd TR, Grant DJ, McMurdo ME, Richards RM. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997;26:375-82.
9. Rothschild JM, Lee TH, Bae T, Bates DW. Clinician use of a palmtop drug reference guide. J Am Med Inform Assoc 2002;9:223-9.
10. Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998;280:1311-6.
11. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
12. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001;30:205-11.
13. Carmichael JM, Alvarez A, Chaput R, DiMaggio J, Magallion H, Mambourg S. Establishment and outcomes of a model primary care pharmacy service system. Am J Health Syst Pharm 2004;61:472-82.
14. Patel RJ, Lyman AE Jr, Clark DR, Hartman TJ, Chester EA, Kicklighter CE. Personal digital assistants for documenting primary care clinical pharmacy services in a health maintenance organization. Am J Health Syst Pharm 2006;63:258-61.
15. Bosinski TJ, Campbell L, Schwartz S. Using a personal digital assistant to document pharmacotherapeutic interventions. Am J Health Syst Pharm 2004;61:931-7.
16. Mutnick AH, Sterba KJ, Peroutka JA, Sloan NE, Beltz EA, Sorenson MK. Cost savings and avoidance from clinical interventions. Am J Health Syst Pharm 1997;54:392-6.
17. Tomechko MA, Strand LM, Morley PC, Cipolle RJ. Q and A from the pharmaceutical care project in Minnesota. Am Pharm 1995;NS35:30-9.
18. Borgsdorf LR, Miano JS, Knapp KK. Pharmacist-managed medication review in a managed care system. Am J Hosp Pharm 1994;51:772-7.
19. Phillips J, Beam S, Brinker A, et al. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm 2001;58:1835-41.
20. Benjamin DM, Pendrak RF. Medication errors: an analysis comparing PHICO's closed claims data and PHICO's event reporting trending system. J Clin Pharmacol 2003;43:754-9.
21. Goode MA, Gums JG. Therapeutic drug monitoring in ambulatory care. Ann Pharmacother 1993;27:502-5.
22. Kim Y, Schepers G. Pharmacist intervention documentation in US health care systems. Hosp Pharm 2003;38:1141-7.
23. Nystrom KK, Foral PA, Wilson AF, Christensen CM, Miller CK. Personal digital assistant (PDA) clinical intervention documentation system: development, implementation, and comparison to a previous paper-based system. Hosp Pharm 2006;41:143-50.
24. Schumock GT, Hutchinson RA, Bilek BA. Comparison of two systems for documenting pharmacist interventions in patient care. Am J Hosp Pharm 1992;49:2211-4.
25. Witt DM, Sadler MA, Shanahan RL, Mazzoli G, Tillman DJ. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest 2005;127:1515-22.
26. Raebel MA, Lyons EE, Andrade SE, et al. Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med 2005;20:1120-6.
27. Howard RL, Avery AJ, Howard PD, Partridge M. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003;12:280-5.
28. Daugherty KK, Kangas K. Enhancing pharmacists' recommendation process in an internal medicine resident clinic. J Am Pharm Assoc 2004;44:89-94.
29. Klopfer JD, Einarson TR. Acceptance of pharmacists' suggestions by prescribers: a literature review. Hosp Pharm 1990;25:830-6.
30. Lee AJ, Boro MS, Knapp KK. Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center. Am J Health Syst Pharm 2002;59:2070-7.
31. Taylor CT, Church CO, Byrd DC. Documentation of clinical interventions by pharmacy faculty, residents, and students. Ann Pharmacother 2000;34:843-7. DOI 10.1345/aph.19310
32. Savage PJ, Pressel SL, Curb D, et al. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension. Arch Intern Med 1998;158:741-51.
33. Carlsen JE, Kober L, Torp-Pederson C, Johansen P. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. Br Med J 1990;300:975-8.
34. Harper R, Ennis CN, Sheridan B, Atkinson AB, Johnston GD, Bell PM. Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension. Br Med J 1994;309:226-30.
35. Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994;330:1852-7.
36. Sookaneknun P, Richards RM, Sanguansermi J, Teerasut C. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann Pharmacother 2004;38:2023-8. Epub 2 Nov 2004. DOI 10.1345/aph.1D605
37. Brockmiller H, Abel SR, Koh-Knox CP, Birk CW. Cost impact of PharmD candidates' drug therapy recommendations. Am J Health Syst Pharm 1999;56:882-4.
38. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001;41:192-9.